| Serial Number | 79387769 |
| Word Mark | BIOSOLVIX |
| Filing Date | Thursday, November 30, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, March 4, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 4, 2025 |
| Description of Mark | The mark consists of "BIOSOLVIX" below the Korean characters that transliterate to "BIOSOLVIX". |
| NOT AVAILABLE | The non-Latin characters in the mark transliterate to "BIOSOLVIX" and this has no meaning in a foreign language. |
| Goods and Services | Medical and health assessment services relating to DNA, genetics and genetic testing; telemedicine services; medical and health care clinic services; medical and health care services; conducting of medical examinations; medical examination services; medical care; medical clinic services; medical information; providing information in the field of medicine; medical screening; provision of information relating to medicine |
| Goods and Services | Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the field of pharmacy; consultancy pertaining to pharmacology; medical research laboratory services; medical research laboratory services; scientific research services for medical purposes; medicine research; scientific analysis and evaluation of medical product development; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; providing information on the testing, inspection and research of medical products; consultancy in the field of testing, inspection, research of medical products; pharmaceutical product evaluation; medical and pharmacological research services; consulting services in the fields of medical research laboratory testing; scientific research in the fields of medicine and health and pharmacology; industrial research in the fields of medicine and health and pharmacology; research in the fields of medicine and surgery and specimen analysis; medical research |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 26, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 26, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Biosolvix.,Co., Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | Biosolvix.,Co., Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Event Date | Event Description |
| Thursday, January 25, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, January 26, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 30, 2024 | APPLICATION FILING RECEIPT MAILED |
| Thursday, June 27, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, July 2, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, July 29, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, July 29, 2024 | REFUSAL PROCESSED BY MPU |
| Monday, July 1, 2024 | NON-FINAL ACTION WRITTEN |
| Saturday, August 17, 2024 | REFUSAL PROCESSED BY IB |
| Saturday, November 30, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, January 22, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 22, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, November 30, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, January 22, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 11, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, February 11, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, February 11, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, February 11, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, February 11, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, February 11, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, February 26, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 4, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 4, 2025 | PUBLISHED FOR OPPOSITION |